PTLD. PTLD: Post-transplant Lymphoproliferative Disorders.

Slides:



Advertisements
Similar presentations
Non-Hodgkin’s Lymphoma
Advertisements

A comparison of the frequency of common lymphoma- associated gene rearrangements among B-Post transplant lymphoproliferative disorders (B-PTLD), B-cell.
Rick Allen.  Leukaemia involves widespread bone marrow involvement and a presence in peripheral blood.  Lymphoma’s arise in discrete tissue masses (commonly.
HAEMATOLOGY MODULE: LYMPHOMA Adult Medical-Surgical Nursing.
Robert R. Brown Evelyne Fliszar Ingrid Kjellin Sandy Kwak Khanh Nguyen Thomas Rand Joong-Mo Ahn,
LYMPHOMAS By DR : Ramy A. Samy.
MANTLE CELL Lymphoma (WITH EMPHASIS ON THE gi TRACT)
Proposed WHO Classification of Lymphoid neoplasm
Lymphoid System Dr. Raid Jastania Dec, By the end of this session you should be able to: –Describe the components of the lymphoid system –List the.
The lymphoreticular system is involved in the defence of the body against microorganisms and foreign substances – i.e. the immune response. Consists of.
Lymphoma Dr. Raid Jastania Dec By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.
Overview on some causes of lymphadenopathy
DIAGNOSING LYMPHOMA AND THE GMCHMDS
Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. NON-HODGKIN L.  immature cells (precursors)  mature cells.
Terry Kotrla, MS, MT(ASCP)BB Topic 3 Autoimmunity Part 8 Immunoproliferative Diseases.
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Lymphoma DR: Gehan Mohamed.
Non-Hodgkin’s lymphomas-definition and epidemiology
Lymphoma David Lee MD, FRCPC. Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of.
EBV positive DLBCL of the elderly 2013/04/01 住院總醫師 王智慧 報告 感謝 蕭樑材大夫 指導.
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Leukopenia, leukocytosis
Edward Camacho Mina 1061 MD4 WINDSOR UNIVERSITY HODGKIN LYMPHOMA.
Post Transplant Lymphoproliferative Disorders (PTLD)
Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Bone Marrow Biopsy Focal involvement by small B-cell neoplasm without significant plasmacytic differentiation (CD3-, CD20+, PAX5+, kappa IHC-, lambda IHC-,
T-cell/histiocyte-rich large B cell lymphoma Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital.
© Cancer Research UK 2005 Registered charity number Table One: Numbers and rates of new cases, non-Hodgkin lymphoma, UK, 2006 EnglandWalesScotlandN.IrelandUK.
The sencond xiangya hospital,central south university
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Myeloproliferative Disorders (MPDs)
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.
Data quality of leukaemia experiences in the Netherlands
Lymphoproliferative disorders. Several clinical conditions in which lymphocytes are produced in excessive quantities ( Lymphocytosis) Lymphoma Malignant.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Unusual anterior Uveitis in a Child. Ocular History  10 year old boy  1/2001: OD>OS  red eyes  iris thickening,  endothelial precipitates, hyphema.
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Acute Leukemia Kristine Krafts, M.D..
(A) the hematopoietic stem cell transplanted (HSCT) recipients only (B) both autologous and allogeneic transplanted recipients (C) both solid organ and.
.. Т-cellВ-cell Lymphoproliferative disorders – lymphatic hemoblastosis, in which the substratum of the tumor are malignisated lymphocytes and/or their.
Hematologic Disorders after Solid Organ Transplantation Passenger Lymphocyte Syndrome Drug-Induced Anemia and Other Cytopenias Thrombotic Microangiopathy.
Chapter 12 The diseases of Hematopoietic and Lymphoid System Liu weiping Department of Pathology West China School of Medicine Sichuan University.
Epstein-Barr Virus: Cancer and Immunosuppression
Asymptomatic lymphadenopathy Mediastinal mass Systemic symptoms Fever, Pruritus Other nonspecific symptoms and paraneoplastic syndromes Intra-abdominal.
Dodo Case 18 A 56 year old male presented with lesions on the forearms. Lesions initially responded to steroids, but then recurred. T-cell gene rearrangement.
Dodo Case 10 A 48 year old male initially presented with spinal cord compression and a paraspinal mass. He received local radiation therapy. Eight months.
Cellular origin of lymphoma
GASTROINTESTINAL MALT LYMPHOMA Scott R. Owens, M.D.
Case 9 A 55 year old male presented with an enlarged axillary lymph node. Staging identified multiple enlarged lymph nodes, and B symptoms, including night.
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
Lymphoma David Lee MD, FRCPC.
Acute Leukemia Kristine Krafts, M.D..
Malignant lymphomas (Non-Hodgkin's lymphomas-NHLs)
Session 7, case 171 Extramedullary Manifestations of Myeloid Neoplasms
Lymphoproliferative disorders
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
Post-transplant Lymphoproliferative disorder of the palate: A Case report and review of the literature O. Sheikh, G. Logan, M. Shorafa, R. Pabla, C. Liew.
Lymphoma Ali Al Khader, M.D. Faculty of Medicine
Alicia K. Morgans, MD, Ran Reshef, MD, Donald E. Tsai, MD, PhD 
LYMPHOPROLIFERATIVE DISORDERS
Presentation transcript:

PTLD

PTLD: Post-transplant Lymphoproliferative Disorders

PTLD: WHO (Jaffe, et al, 2001) –Lymphoid proliferation or lymphoma that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. –PTLDs comprise a spectrum ranging from early EBV-driven polyclonal proliferations resembling infectious mononucleosis to EBV(+) or EBV(-) lymphomas of predominantly B-cell or less often T-cell type.

Post-transplant Lymphoproliferative Disorders- PTLD Early lesions Polymorphic PTLD Monomorphic PTLD (Classify according to lymphoma classification) Hodgkin lymphoma and Hodgkin-like PTLD

1. Early lesions Reactive plasmacytic hyperplasia Infectious Mononucleosis-like Possibly these are overlapping syndromes.

Infectious mononucleosis-like

Infectious mononucleosis-like, cont.

1. Early lesions: Characteristics Lymphoid proliferation with preservation of architecture of the involved tissue. Younger age, solid organ transplants EBV + (If negative should not call PTLD) Polyclonal. Tend to regress with reduction in immunosuppression Can be fatal!

2. Polymorphic PTLD 15 Y/O F 125 days post unrelated donor cord transplant for MDS now with GI symptoms and Acute GVHD. Jejunal Biopsy

2. Polymorphic PTLD, cont. EBER CD20

Polymorphic PTLD: Characteristics Destructive lesions composed of immunoblasts, plasma cells, and intermediate forms that efface the architecture. Full range of B-cell maturation. Clonal proliferations. EBV + Some will regress with reduction in immunosuppression.

3. Monomorphic PTLD B-cell neoplasms –Diffuse large B-cell lymphoma –Burkitt lymphoma –Myeloma –Plasmacytoma T-cell neoplasms –Peripheral T-cell lymphoma, NOS –Other types

3. Monomorphic PTLD: Case 1: DLBCL Pt. E.K.: 72 Male 8 mos. post renal transplant now with inguinal lymphadenopathy.

3. Monomorphic PTLD:DLBCL LMP1 CD20

Monomorphic PTLD: Case 2: DLBCL Pt R.E.: 46 Y/O M 34 months post liver transplant now with lung and mediastinal masses.

Case 2: DLBCL CD 20 LMP1

Case 3: Myeloma Pt. JS: 52 Y/O M 4 yrs post renal transplant now with pathologic fracture of left femur. Lambda LMP1

Monomorphic PTLD: Characteristics Can be diagnosed as lymphoma on morphologic grounds, and are classified accordingly (T- vs. B-cell). Most are EBV positive. Clonal proliferations. Tend to progress and require chemotherapy.

4. Hodgkin Lymphoma Mixed cellularity most common followed by Nodular sclerosis Lymphocyte depleted least common

Which PTLDs respond to reduction of immunosuppression? Morphology Immunophenotype EBV status Clonality Bcl-6 mutation: 3q27 t(3:22)(q27:q11) is associated with failure to regress in polymorphic and monomorphic PTLDs.